Numerous studies have assessed the progression of amyloid and tau pathology alongside cognitive decline in Down syndrome‐associated Alzheimer's disease (DSAD), demonstrating a similar, but accelerated, Alzheimer's disease (AD) time course.2, 3, 4. The gene discussed is MAPT; the disease is amyloidosis.